G-treeBNT
Business Services · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
116 Village Blvd Ste 200, Princeton, New...Phone Number
+82 317867800Website
www.gtreebnt.comRevenue
$17.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About G-treeBNT
GtreeBNT Co., Ltd. (www.gtreebnt.com) is a clinical development pharmaceutical company listed on the Korean stock market that aims to acquire the rights to early clinical stage pipeline pharmaceuticals targeted at diseases with unmet needs, including rare diseases. GtreeBNT plans to rapidly develop the pharmaceuticals through additional studies, formulation development, and clinical trials for commercialization. Currently, its U.S. subsidiary, ReGenTree, LLC (www.regentreellc.com), is conducting a second Phase 3 clinical trial (ARISE-2) for dry eye syndrome (DES) and a Phase 3 trial (SEER-1) for the orphan ocular disease neurotrophic keratopathy (NK) using RGN-259 eye drops. In addition, GtreeBNT is conducting a Phase 1b trial for the orphan disease glioblastoma multiforme (GBM) using OKN-007 in U.S.Explore more
G-treeBNT Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is G-treeBNT your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
G-treeBNT, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if G-treeBNT had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if G-treeBNT is spiking on competitors!
Funding: Get notified immidiatlly once G-treeBNT has new funding data
Check if G-treeBNT has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on G-treeBNT recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at G-treeBNT
Product Launch: Get notified when G-treeBNT launches new products
Recommended Actions
Reach out to Masked Content who joined G-treeBNT as Masked Content
Find 3 more new buyers
Compare Similar Companies to G-treeBNT
Compare insights from companies similar to G-treeBNT, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
G-treeBNT is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
G-treeBNT is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about G-treeBNT.
G-treeBNT Tech Stack
A closer look at the technologies used by G-treeBNT
See more technologies
G-treeBNT News & Media
Oblato Announces Discussion Outcome with FDA for Development of OKN-007 for Diffuse Intrinsic Pontine Glioma
PRINCETON, N.J., Dec. 10, 2020 /PRNewswire/ -- Oblato, Inc. (the Company), a wholly owned U.S. subsidiary of the Korean biotech company GtreeBNT Co., Ltd., announced it had official discussions with the FDA on a detailed plan for a phase 1/2 clinical trial to start developing a new...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding G-treeBNT
Sign Up For FreeTo access detailed company insights
GtreeBNT Co., Ltd. (www.gtreebnt.com) is a clinical development pharmaceutical company listed on the Korean stock market that aims to acquire the rights to early clinical stage pipeline pharmaceuticals targeted at diseases with unmet needs, including rare diseases. GtreeBNT plans to rapidly develop the pharmaceuticals through additional studies, fo... Read More
